| Browse by: | Sort by: |
New Actions of Old Hormones
Chair
Hans H Zingg, MD,PHD
McGill Univ, Montreal, QC
Available
New Actions of Old Hormones
Oxytocin and Stress
Robert J Handa, PHD
Colorado State Univ, Fort Collins, CO
Available
New Actions of Old Hormones
Vasopressin and Falls & Fractures
Joseph G Verbalis, MD
Georgetown Univ, Washington, DC
Available
Discovery and Deorphanization of Neuropeptides and Their Receptors
Discovery and Function of Novel Neuropeptides and Peptide Hormones
James W Checco, PhD
University of Illinois at Urbana-Champaign, Urbana, IL
Permission not
granted for presentation
granted for presentation
Discovery and Deorphanization of Neuropeptides and Their Receptors
Novel Neuropeptide GPCRs Implicated in Feeding and Obesity
Lakshmi A. Devi, Ph.D.
Mount Sinai School of Medicine, New York, NY
Available
Discovery and Deorphanization of Neuropeptides and Their Receptors
Fatty Acid Receptors and Glucose Homeostasis
Stefan Offermanns, PhD
Max-Planck-Institut für Herz- und Lungenforschung, Bad Nauheim, Bad Nauheim, Germany
Permission not
granted for presentation
granted for presentation
A Year in Progress in GPCR Research
A Year in Progress in GPCR Research
Deborah L Segaloff, PhD
Univ of Iowa Carver Coll of Med, Iowa City, IA
Permission not
granted for presentation
granted for presentation
K/O Rounds: Why Endocrine Science Matters - in 3 Minutes
(K/O Round) Lxrbeta Antagonism Mitigates Glucocorticoid-Induced Gluconeogenesis without Altering Immune Suppression
Rucha Patel, PhD
University of Toronto, Toronto, ON
Available
K/O Rounds: Why Endocrine Science Matters - in 3 Minutes
(K/O Round) Exploring Biased G Protein-Coupled Receptor Agonism with Biophsyical Probes
Erik G. Strungs
Medical University of South Carolina, Charleston, SC
Available
Epigenetics in Diabetes: From Diagnosis to Complications
Epigenetic Changes in Patients with Type 2 Diabetes and Impact on Insulin Secretion and Action
Charlotte Ling, PhD
Lund University Diabetes Centre, Lund University, Clinical Research Centre, Malmö, Sweden
Free
Slides + audio
Epigenetics in Diabetes: From Diagnosis to Complications
Epigenomic and Transcriptional Mechanisms of Insulin Resistance
Sona Kang, PhD
University of California-Berkeley, Berkeley, CA
Available
Epigenetics in Diabetes: From Diagnosis to Complications
Epigenomic Identification of Regulatory Networks Underlying Insulin Resistance in Human Adipocytes
Linus Tzu-Yen Tsai, MD, PhD
Beth Israel Deaconness Medical Center, Boston, MA
Permission not
granted for presentation
granted for presentation
Epigenetics in Diabetes: From Diagnosis to Complications
Epigenetics in Diabetic Complications and Metabolic Memory
Rama Natarajan, PhD
Beckman Research Institute of City of Hope, Duarte, CA
Permission not
granted for presentation
granted for presentation
IGF Tumor Microenvironment: Bench to Bedside
IGF/Insulin Receptor and Wnt Signaling Interactions in Mammary Development and Cancer
Teresa L Wood, PhD
New Jersey Medical School, Rutgers Biomedical & Health Sciences, Newark, NJ
Available
IGF Tumor Microenvironment: Bench to Bedside
The roles of IGF in breast cancer metastasis to bone
Xiang (Shawn) Zhang, Ph.D.
Baylor College of Medicine, Houston, TX
Available
IGF Tumor Microenvironment: Bench to Bedside
Targeting GH-IGF for Breast Cancer Prevention
David L Kleinberg, MD
New York University, New York, NY
Available
GPCR Modulators of Beta Cell Survival and Function
Peptide Homodimers Regulating Beta Cell Function and Energy Homeostasis
James Neville Leonard, Ph.D.
Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, PA
Available
GPCR Modulators of Beta Cell Survival and Function
Is GLP-1 a hormone: If and when?
David A D'Alessio, MD
Univ of Cincinnati, Cincinnati, OH
Available
GPCR Modulators of Beta Cell Survival and Function
GLP-1 Signaling: Not Just GPCRs
Joel Francis Habener
Mass Gen Hosp, Boston, MA
Available
How Do We Think About Aldosterone in 2015?
New Mechanisms and Targets in Primary Aldosteronism
Richard Warth
Universitat Regensburg, Regensburg, Germany
Permission not
granted for presentation
granted for presentation
How Do We Think About Aldosterone in 2015?
Cancer and Aldosterone: Unanticipated Consequences of Hyperaldosteronism
Katharina Lang
University of Birmingham, Birmingham, England
Available
How Do We Think About Aldosterone in 2015?
Adrenal Vein Sampling
Anna Riester
University of Munich, Munich, Germany
Available
How Do We Think About Aldosterone in 2015?
Perspectives on the Renaissance in Primary Aldosteronism
William F Young, Jr., MD, MSc
Mayo Clinic, Rochester, MN
Available
How Do We Think About Aldosterone in 2015?
Questions and Answers
Katharina Lang
University of Birmingham, Birmingham, England
Anna Riester
University of Munich, Munich, Germany
Available
Prolactin: Beyond Reproduction
PRL in Inflammatory Arthritis
Carmen Clapp, PhD
Neurobiology Institute, National University of Mexico (UNAM), Queretaro, Mexico
Available
